Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Takeshi Kurata

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Procedures

Intranasal Administration

Chemicals & Drugs

Disorders

Orthomyxoviridae Infections

Anatomy

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kitagawa Yoshinori; Maeda-Sato Masae; Tanaka Keiko; Tobiume Minoru; Sawa Hirofumi; Hasegawa Hideki; Kojima Asato; Hall William W; Kurata Takeshi; Sata Tetsutaro; Takahashi Hidehiro
Covalent bonded Gag multimers in human immunodeficiency virus type-1 particles.
Takahashi Hidehiro; Ohtaki Naohiro; Maeda-Sato Masae; Tanaka Michiko; Tanaka Keiko; Sawa Hirofumi; Ishikawa Toyokazu; Takamizawa Akihisa; Takasaki Tomohiko; Hasegawa Hideki; Sata Tetsutaro; Hall William W; Kurata Takeshi; Kojima Asato
Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus.
Saijo Masayuki; Ami Yasushi; Suzaki Yuriko; Nagata Noriyo; Iwata Naoko; Hasegawa Hideki; Iizuka Itoe; Shiota Tomoyuki; Sakai Kouji; Ogata Momoko; Fukushi Shuetsu; Mizutani Tetsuya; Sata Tetsutaro; Kurata Takeshi; Kurane Ichiro; Morikawa Shigeru
Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Takeshi Kurata (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kitagawa Yoshinori; Maeda-Sato Masae; Tanaka Keiko; Tobiume Minoru; Sawa Hirofumi; Hasegawa Hideki; Kojima Asato; Hall William W; Kurata Takeshi; Sata Tetsutaro; Takahashi Hidehiro
Covalent bonded Gag multimers in human immunodeficiency virus type-1 particles.
Microbiology and immunology 2009;53(11):609-20.
2009: Takahashi Hidehiro; Ohtaki Naohiro; Maeda-Sato Masae; Tanaka Michiko; Tanaka Keiko; Sawa Hirofumi; Ishikawa Toyokazu; Takamizawa Akihisa; Takasaki Tomohiko; Hasegawa Hideki; Sata Tetsutaro; Hall William W; Kurata Takeshi; Kojima Asato
Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus.
Microbes and infection / Institut Pasteur 2009;11(13):1019-28.
2009: Saijo Masayuki; Ami Yasushi; Suzaki Yuriko; Nagata Noriyo; Iwata Naoko; Hasegawa Hideki; Iizuka Itoe; Shiota Tomoyuki; Sakai Kouji; Ogata Momoko; Fukushi Shuetsu; Mizutani Tetsuya; Sata Tetsutaro; Kurata Takeshi; Kurane Ichiro; Morikawa Shigeru
Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates.
The Journal of general virology 2009;90(Pt 9):2266-71.
2009: Kataoka Michiyo; Yamamoto Akihiko; Ochiai Masaki; Harashima Ayako; Nagata Noriyo; Hasegawa Hideki; Kurata Takeshi; Horiuchi Yoshinobu
Comparison of acellular pertussis-based combination vaccines by Japanese control tests for toxicities and laboratory models for local reaction.
Vaccine 2009;27(13):1881-8.
2009: Hasegawa Hideki; Ichinohe Takeshi; Ainai Akira; Tamura Shin-Ichi; Kurata Takeshi
Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses.
Therapeutics and clinical risk management 2009;5(1):125-32.
2008: Saijo Masayuki; Ami Yasushi; Suzaki Yuriko; Nagata Noriyo; Iwata Naoko; Hasegawa Hideki; Ogata Momoko; Fukushi Shuetsu; Mizutani Tetsuya; Iizuka Itoe; Sakai Koji; Sata Tetsutaro; Kurata Takeshi; Kurane Ichiro; Morikawa Shigeru
Diagnosis and assessment of monkeypox virus (MPXV) infection by quantitative PCR assay: differentiation of Congo Basin and West African MPXV strains.
Japanese journal of infectious diseases 2008;61(2):140-2.
2007: Ichinohe Takeshi; Tamura Shin-Ichi; Kawaguchi Akira; Ninomiya Ai; Imai Masaki; Itamura Shigeyuki; Odagiri Takato; Tashiro Masato; Takahashi Hidehiro; Sawa Hirofumi; Mitchell William M; Strayer David R; Carter William A; Chiba Joe; Kurata Takeshi; Sata Tetsutaro; Hasegawa Hideki
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
The Journal of infectious diseases 2007;196(9):1313-20.
2007: Ogawa-Goto Kiyoko; Tanaka Keiko; Ueno Tomonori; Tanaka Keisuke; Kurata Takeshi; Sata Tetsutaro; Irie Shinkichi
p180 is involved in the interaction between the endoplasmic reticulum and microtubules through a novel microtubule-binding and bundling domain.
Molecular biology of the cell 2007;18(10):3741-51.
2007: Ichinohe Takeshi; Kawaguchi Akira; Tamura Shin-ichi; Takahashi Hidehiro; Sawa Hirofumi; Ninomiya Ai; Imai Masaki; Itamura Shigeyuki; Odagiri Takato; Tashiro Masato; Chiba Joe; Sata Tetsutaro; Kurata Takeshi; Hasegawa Hideki
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.
Microbes and infection / Institut Pasteur 2007;9(11):1333-40.
2007: Saijo Masayuki; Georges-Courbot Marie-Claude; Marianneau Philippe; Romanowski Victor; Fukushi Shuetsu; Mizutani Tetsuya; Georges Alain-Jean; Kurata Takeshi; Kurane Ichiro; Morikawa Shigeru
Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.
Clinical and vaccine immunology : CVI 2007;14(9):1182-9.
2007: Ichinohe Takeshi; Nagata Noriyo; Strong Peter; Tamura Shin-ichi; Takahashi Hidehiro; Ninomiya Ai; Imai Masaki; Odagiri Takato; Tashiro Masato; Sawa Hirofumi; Chiba Joe; Kurata Takeshi; Sata Tetsutaro; Hasegawa Hideki
Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus.
Journal of medical virology 2007;79(6):811-9.
2007: Hasegawa Hideki; Ichinohe Takeshi; Tamura Shin-ichi; Kurata Takeshi
Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.
Expert review of vaccines 2007;6(2):193-201.
2007: Katano Harutaka; Sato Yuko; Tsutsui Yoshihiro; Sata Tetsutaro; Maeda Akihiko; Nozawa Naoki; Inoue Naoki; Nomura Yasuya; Kurata Takeshi
Pathogenesis of cytomegalovirus-associated labyrinthitis in a guinea pig model.
Microbes and infection / Institut Pasteur 2007;9(2):183-91.
2007: Inoue Kenji; Sugiyama Akira; Reid Patrick C; Ito Yukio; Miyauchi Katsumi; Mukai Sei; Sagara Mina; Miyamoto Kyoko; Satoh Hirokazu; Kohno Isao; Kurata Takeshi; Ota Hiroshi; Mantovani Alberto; Hamakubo Takao; Daida Hiroyuki; Kodama Tatsuhiko
Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(1):161-7.
2007: Kinomoto Masanobu; Kanno Takayuki; Shimura Mari; Ishizaka Yukihito; Kojima Asato; Kurata Takeshi; Sata Tetsutaro; Tokunaga Kenzo
All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition.
Nucleic acids research 2007;35(9):2955-64.
2006: Asahi-Ozaki Yasuko; Itamura Shigeyuki; Ichinohe Takeshi; Strong Peter; Tamura Shin-Ichi; Takahashi Hidehiro; Sawa Hirofumi; Moriyama Masami; Tashiro Masato; Sata Tetsutaro; Kurata Takeshi; Hasegawa Hideki
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
Microbes and infection / Institut Pasteur 2006;8(12-13):2706-14.
2006: Maeda Masae; Sawa Hirofumi; Tobiume Minoru; Tokunaga Kenzo; Hasegawa Hideki; Ichinohe Takeshi; Sata Tetsutaro; Moriyama Masami; Hall William W; Kurata Takeshi; Takahashi Hidehiro
Tristetraprolin inhibits HIV-1 production by binding to genomic RNA.
Microbes and infection / Institut Pasteur 2006;8(11):2647-56.
2006: Ichinohe Takeshi; Watanabe Izumi; Tao Eriko; Ito Satoshi; Kawaguchi Akira; Tamura Shin-ichi; Takahashi Hidehiro; Sawa Hirofumi; Moriyama Masami; Chiba Joe; Komase Katsuhiro; Suzuki Yujiro; Kurata Takeshi; Sata Tetsutaro; Hasegawa Hideki
Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
Journal of medical virology 2006;78(7):954-63.
2006: Saijo Masayuki; Ami Yasushi; Suzaki Yuriko; Nagata Noriyo; Iwata Naoko; Hasegawa Hideki; Ogata Momoko; Fukushi Shuetsu; Mizutani Tetsuya; Sata Tetsutaro; Kurata Takeshi; Kurane Ichiro; Morikawa Shigeru
LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox.
Journal of virology 2006;80(11):5179-88.
2006: Saijo Masayuki; Niikura Masahiro; Ikegami Tetsuro; Kurane Ichiro; Kurata Takeshi; Morikawa Shigeru
Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.
Clinical and vaccine immunology : CVI 2006;13(4):444-51.
2006: Hasegawa Hideki; Sawa Hirofumi; Lewis Martha J; Orba Yasuko; Sheehy Noreen; Yamamoto Yoshie; Ichinohe Takeshi; Tsunetsugu-Yokota Yasuko; Katano Harutaka; Takahashi Hidehiro; Matsuda Junichiro; Sata Tetsutaro; Kurata Takeshi; Nagashima Kazuo; Hall William W
Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.
Nature medicine 2006;12(4):466-72.
2006: Takahashi Hidehiro; Maeda Masae; Sawa Hirofumi; Hasegawa Hideki; Moriyama Masami; Sata Tetsutaro; Hall William W; Kurata Takeshi
Dicer and positive charge of proteins decrease the stability of RNA containing the AU-rich element of GM-CSF.
Biochemical and biophysical research communications 2006;340(3):807-14.
2005: Morikawa Shigeru; Sakiyama Tokuki; Hasegawa Hideki; Saijo Masayuki; Maeda Akihiko; Kurane Ichiro; Maeno Go; Kimura Junko; Hirama Chie; Yoshida Teruhiko; Asahi-Ozaki Yasuko; Sata Tetsutaro; Kurata Takeshi; Kojima Asato
An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Journal of virology 2005;79(18):11873-91.
2005: Kinomoto Masanobu; Appiah-Opong Regina; Brandful J A M; Yokoyama Masaru; Nii-Trebi Nicholas; Ugly-Kwame Evelyn; Sato Hironori; Ofori-Adjei David; Kurata Takeshi; Barre-Sinoussi Françoise; Sata Tetsutaro; Tokunaga Kenzo
HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(2):243-51.
2005: Kinomoto Masanobu; Yokoyama Masaru; Sato Hironori; Kojima Asato; Kurata Takeshi; Ikuta Kazuyoshi; Sata Tetsutaro; Tokunaga Kenzo
Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.
Journal of virology 2005;79(10):5996-6004.
2005: Saijo Masayuki; Niikura Masahiro; Maeda Akihiko; Sata Tetsutaro; Kurata Takeshi; Kurane Ichiro; Morikawa Shigeru
Characterization of monoclonal antibodies to Marburg virus nucleoprotein (NP) that can be used for NP-capture enzyme-linked immunosorbent assay.
Journal of medical virology 2005;76(1):111-8.
2005: Ohnishi Kazuo; Sakaguchi Masahiro; Kaji Tomohiro; Akagawa Kiyoko; Taniyama Tadayoshi; Kasai Masataka; Tsunetsugu-Yokota Yasuko; Oshima Masamichi; Yamamoto Kiichi; Takasuka Naomi; Hashimoto Shu-ichi; Ato Manabu; Fujii Hideki; Takahashi Yoshimasa; Morikawa Shigeru; Ishii Koji; Sata Tetsutaro; Takagi Hirotaka; Itamura Shigeyuki; Odagiri Takato; Miyamura Tatsuo; Kurane Ichiro; Tashiro Masato; Kurata Takeshi; Yoshikura Hiroshi; Takemori Toshitada
Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies.
Japanese journal of infectious diseases 2005;58(2):88-94.
2005: Ichinohe Takeshi; Watanabe Izumi; Ito Satoshi; Fujii Hideki; Moriyama Masami; Tamura Shin-Ichi; Takahashi Hidehiro; Sawa Hirofumi; Chiba Joe; Kurata Takeshi; Sata Tetsutaro; Hasegawa Hideki
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Journal of virology 2005;79(5):2910-9.
2005: Hasegawa Hideki; Ichinohe Takeshi; Strong Peter; Watanabe Izumi; Ito Satoshi; Tamura Shin-Ichi; Takahashi Hidehiro; Sawa Hirofumi; Chiba Joe; Kurata Takeshi; Sata Tetsutaro
Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
Journal of medical virology 2005;75(1):130-6.
2004: Iwasaki Takuya; Itamura Shigeyuki; Nishimura Hidekazu; Sato Yuko; Tashiro Masato; Hashikawa Tsutomu; Kurata Takeshi
Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation.
Acta neuropathologica 2004;108(6):485-92.
2004: Hasegawa Hideki; Katano Harutaka; Tanno Masataka; Masuo Shigeru; Ae Takako; Sato Yuko; Takahashi Hidehiro; Iwasaki Takuya; Kurata Takeshi; Sata Tetsutaro
BCL-6-positive human herpesvirus 8-associated solid lymphoma arising from liver and spleen as multiple nodular lesions.
Leukemia & lymphoma 2004;45(10):2169-72.
2004: Asahi-Ozaki Yasuko; Yoshikawa Tomoki; Iwakura Yoichiro; Suzuki Yujiro; Tamura Shin-Ichi; Kurata Takeshi; Sata Tetsutaro
Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.
Journal of medical virology 2004;74(2):328-35.
2004: Yoshikawa Tomoki; Matsuo Keiko; Matsuo Kazutoshi; Suzuki Yujiro; Nomoto Akio; Tamura Shin-Ichi; Kurata Takeshi; Sata Tetsutaro
Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice.
The Journal of general virology 2004;85(Pt 8):2339-46.
2004: Mutoh Eiji; Ishikawa Toyokazu; Takamizawa Akihisa; Kurata Takeshi; Sata Tetsutaro; Kojima Asato
Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone.
Vaccine 2004;22(20):2599-608.
2004: Iwasaki T; Inoue S; Tanaka K; Sato Y; Morikawa S; Hayasaka D; Moriyama M; Ono T; Kanai S; Yamada A; Kurata T
Characterization of Oita virus 296/1972 of Rhabdoviridae isolated from a horseshoe bat bearing characteristics of both lyssavirus and vesiculovirus.
Archives of virology 2004;149(6):1139-54.
2004: Ochiai Masaki; Kataoka Michiyo; Toyoizumi Hiromi; Yamamoto Akihiko; Kamachi Kazunari; Arakawa Yoshichika; Kurata Takeshi; Horiuchi Yoshinobu
Endotoxin content in Haemophilus influenzae type b vaccine.
Japanese journal of infectious diseases 2004;57(2):58-9.
2004: Harada Takayuki; Tatsumi Masashi; Takahashi Hidehiro; Sata Tetsutaro; Kurata Takeshi; Kojima Asato
Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry.
Microbes and infection / Institut Pasteur 2004;6(5):421-8.
2004: Nagata Noriyo; Iwasaki Takuya; Ami Yasushi; Sato Yuko; Hatano Ikuyoshi; Harashima Ayako; Suzaki Yuriko; Yoshii Takao; Hashikawa Tsutomu; Sata Tetsutaro; Horiuchi Yoshinobu; Koike Satoshi; Kurata Takeshi; Nomoto Akio
A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
Virology 2004;321(1):87-100.
2004: Takahashi Hiroshi; Keim Paul; Kaufmann Arnold F; Keys Christine; Smith Kimothy L; Taniguchi Kiyosu; Inouye Sakae; Kurata Takeshi
Bacillus anthracis incident, Kameido, Tokyo, 1993.
Emerging infectious diseases 2004;10(1):117-20.
2004: Takahashi Hidehiro; Sawa Hirofumi; Hasegawa Hideki; Nagashima Kazuo; Sata Tetsutaro; Kurata Takeshi
Topoisomerase I dissociates human immunodeficiency virus type 1 reverse transcriptase from genomic RNAs.
Biochemical and biophysical research communications 2004;313(4):1073-8.
2004: Ueno Tomonori; Tokunaga Kenzo; Sawa Hirofumi; Maeda Masae; Chiba Joe; Kojima Asato; Hasegawa Hideki; Shoya Yuko; Sata Tetsutaro; Kurata Takeshi; Takahashi Hidehiro
Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1).
Microbiology and immunology 2004;48(2):111-8.
2003: Watanabe Izumi; Ross Ted M; Tamura Shin-ichi; Ichinohe Takeshi; Ito Satoshi; Takahashi Hidehiro; Sawa Hirofumi; Chiba Joe; Kurata Takeshi; Sata Tetsutaro; Hasegawa Hideki
Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin.
Vaccine 2003;21(31):4532-8.
2003: Inoue Satoshi; Sato Yuko; Hasegawa Hideki; Noguchi Akira; Yamada Akio; Kurata Takeshi; Iwasaki Takuya
Cross-reactive antigenicity of nucleoproteins of lyssaviruses recognized by a monospecific antirabies virus nucleoprotein antiserum on paraffin sections of formalin-fixed tissues.
Pathology international 2003;53(8):525-33.
2003: Kojima Asato; Yasuda Atsushi; Asanuma Hideki; Ishikawa Toyokazu; Takamizawa Akihisa; Yasui Kotaro; Kurata Takeshi
Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine.
Journal of virology 2003;77(16):8745-55.
2003: Ogawa-Goto K; Tanaka K; Gibson W; Moriishi E; Miura Y; Kurata T; Irie S; Sata T
Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid.
Journal of virology 2003;77(15):8541-7.
2003: Shoya Yuko; Tokunaga Kenzo; Sawa Hirofumi; Maeda Masae; Ueno Tomonori; Yoshikawa Tomoki; Hasegawa Hideki; Sata Tetsutaro; Kurata Takeshi; Hall William W; Cullen Bryan R; Takahashi Hidehiro
Human topoisomerase I promotes HIV-1 proviral DNA synthesis: implications for the species specificity and cellular tropism of HIV-1 infection.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(14):8442-7.
2003: Ito Reiko; Ozaki Yasuko Asahi; Yoshikawa Tomoki; Hasegawa Hideki; Sato Yuko; Suzuki Yujiro; Inoue Ryosuke; Morishima Tsuneo; Kondo Naomi; Sata Tetsutaro; Kurata Takeshi; Tamura Shin-ichi
Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia.
Vaccine 2003;21(19-20):2362-71.
2003: Sata Tetsutaro; Shimazaki Kae; Sato Yuko; Kurata Takeshi
[Viral hemorrhagic fever]
Nippon rinsho. Japanese journal of clinical medicine 2003;61 Suppl 2():281-7.
2003: Niikura Masahiro; Ikegami Tetsuro; Saijo Masayuki; Kurata Takeshi; Kurane Ichiro; Morikawa Shigeru
Analysis of linear B-cell epitopes of the nucleoprotein of ebola virus that distinguish ebola virus subtypes.
Clinical and diagnostic laboratory immunology 2003;10(1):83-7.
2002: Hasegawa Hideki; Tatsumi Masashi; Ogawa-Goto Kiyoko; Takahashi Hidehiro; Kojima Asato; Iwasaki Takuya; Kurata Takeshi; Sata Tetsutaro; Takeuchi Toshiyuji; Sheehy Noreen; Sawa Hirofumi; Nagashima Kazuo; Hall William W
Processing of the HTLV-II envelope precursor glycoprotein gp63 by furin is essential for cell fusion activity.
AIDS research and human retroviruses 2002;18(17):1253-60.
2002: Yoshikawa Tomoki; Suzuki Yujiro; Nomoto Akio; Sata Tetutaro; Kurata Takeshi; Tamura Shin ichi
Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.
Vaccine 2002;21(1-2):60-6.
2002: Watanabe Izumi; Hagiwara Yukari; Kadowaki Shin-etsu; Yoshikawa Tomoki; Komase Katsuhiro; Aizawa Chikara; Kiyono Hiroshi; Takeda Yoshifumi; McGhee Jerry R; Chiba Joe; Sata Tetsutaro; Kurata Takeshi; Tamura Shin-ichi
Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K).
Vaccine 2002;20(29-30):3443-55.
2002: Takahashi Hidehiro; Sawa Hirofumi; Hasegawa Hideki; Sata Tetsutaro; Hall William; Kurata Takeshi
Binding and dissociation of human topoisomerase I with hairpin-loop RNAs: implications for the regulation of HIV-1 replication.
Biochemical and biophysical research communications 2002;297(3):593-9.
2002: Harada Takayuki; Tsunetsugu-Yokota Yasuko; Koyanagi Yoshio; Sata Tetsutaro; Kurata Takeshi; Kojima Asato
Role of nucleotide sequences in the V3 region in efficient replication of CCR5-utilizing human immunodeficiency virus type 1 in macrophages.
Virology 2002;299(2):192-203.
2002: Takahashi Hidehiro; Sawa Hirofumi; Hasegawa Hideki; Shoya Yuko; Sata Tetsutaro; Hall William W; Nagashima Kazuo; Kurata Takeshi
Topoisomerase I and ATP activate cDNA synthesis of human immunodeficiency virus type 1.
Biochemical and biophysical research communications 2002;294(2):509-17.
2002: Takahashi Hidehiro; Sawa Hirofumi; Hasegawa Hideki; Sata Tetsutaro; Hall William W; Nagashima Kazuo; Kurata Takeshi
Reconstitution of cleavage of human immunodeficiency virus type-1 (HIV-1) RNAs.
Biochemical and biophysical research communications 2002;293(3):1084-91.
2002: Asahi Yasuko; Yoshikawa Tomoki; Watanabe Izumi; Iwasaki Takuya; Hasegawa Hideki; Sato Yuko; Shimada Shin-ichiro; Nanno Masanobu; Matsuoka Yoshiaki; Ohwaki Makoto; Iwakura Yoichiro; Suzuki Yujiro; Aizawa Chikara; Sata Tetutaro; Kurata Takeshi; Tamura Shin-ichi
Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(6):2930-8.
2002: Ogawa-Goto K; Irie S; Omori A; Miura Y; Katano H; Hasegawa H; Kurata T; Sata T; Arao Y
An endoplasmic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegument protein encoded by UL48.
Journal of virology 2002;76(5):2350-62.
2002: Hasegawa Hideki; Kadowaki Shin etsu; Watanabe Izumi; Aizawa Hiroshi; Takahashi Hidehiro; Iwasaki Takuya; Tamura Shin ichi; Kurata Takeshi; Sata Tetsutaro
Persistent infection of influenza virus in irradiated mice and its prevention by intranasal vaccination.
Vaccine 2002;20(7-8):1050-7.
2001: Keim P; Smith K L; Keys C; Takahashi H; Kurata T; Kaufmann A
Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan.
Journal of clinical microbiology 2001;39(12):4566-7.
2001: Ishikawa K; Janssens W; Banor J S; Shinno T; Piedade J; Sata T; Ampofo W K; Brandful J A; Koyanagi Y; Yamamoto N; Canas-Ferreira W F; Adu-Sarkodie Y; Kurata T
Genetic analysis of HIV type 2 from Ghana and Guinea-Bissau, West Africa.
AIDS research and human retroviruses 2001;17(17):1661-3.
2001: Katano H; Ogawa-Goto K; Hasegawa H; Kurata T; Sata T
Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies.
Virology 2001;286(2):446-55.
2001: Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
Vaccine 2001;19(28-29):3981-9.
2001: Nagata N; Iwasaki T; Ami Y; Harashima A; Hatano I; Suzaki Y; Yoshii K; Yoshii T; Nomoto A; Kurata T
Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys.
Vaccine 2001;19(23-24):3201-8.
2001: Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S
Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
Vaccine 2001;19(15-16):2071-9.
2001: Hagiwara Y; Iwasaki T; Asanuma H; Sato Y; Sata T; Aizawa C; Kurata T; Tamura S
Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain.
Vaccine 2001;19(13-14):1652-60.
2001: Chen Z; Kadowaki S; Hagiwara Y; Yoshikawa T; Sata T; Kurata T; Tamura S
Protection against influenza B virus infection by immunization with DNA vaccines.
Vaccine 2001;19(11-12):1446-55.
2000: Arakawa Y; Ike Y; Nagasawa M; Shibata N; Doi Y; Shibayama K; Yagi T; Kurata T
Trends in antimicrobial-drug resistance in Japan.
Emerging infectious diseases 2000;6(6):572-5.
2000: Nishimura H; Itamura S; Iwasaki T; Kurata T; Tashiro M
Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection.
The Journal of general virology 2000;81(Pt 10):2503-10.
2000: Takahashi H; Iwata T; Kitagawa Y; Shoya Y; Takahashi R H; Nagashima K; Kurata T
Monoclonal antibodies against topoisomerase I suppressed DNA relaxation and HIV-1 cDNA synthesis.
Hybridoma 2000;19(4):331-4.
2000: Chen Z; Kadowaki S; Hagiwara Y; Yoshikawa T; Matsuo K; Kurata T; Tamura S
Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.
Vaccine 2000;18(28):3214-22.
2000: Tamura S I; Kurata T
A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
Japanese journal of infectious diseases 2000;53(3):98-106.
2000: Kadowaki S; Chen Z; Asanuma H; Aizawa C; Kurata T; Tamura S
Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation.
Vaccine 2000;18(25):2779-88.
2000: Matsuo K; Yoshikawa T; Asanuma H; Iwasaki T; Hagiwara Y; Chen Z; Kadowaki S E; Tsujimoto H; Kurata T; Tamura S I
Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin).
Vaccine 2000;18(24):2713-22.
2000: Hasegawa H; Kadowaki S; Takahashi H; Iwasaki T; Tamura S; Kurata T
Protection against influenza virus infection by nasal vaccination in advance of sublethal irradiation.
Vaccine 2000;18(23):2560-5.
2000: Katano H; Sato Y; Kurata T; Mori S; Sata T
Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.
Virology 2000;269(2):335-44.
2000: Yoshikawa T; Uchida T; Naito S; Horino A; Taneichi M; Kato H; Komuro K; Nakano Y; Mori M; Nishinohara S; Chiba J; Kurata T; Tamura S
Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract.
International archives of allergy and immunology 2000;121(2):108-15.
2000: Matsuo K; Iwasaki T; Asanuma H; Yoshikawa T; Chen Z; Tsujimoto H; Kurata T; Tamura S S
Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination.
Vaccine 2000;18(14):1344-50.
1999: Takahashi H; Iwata T; Kitagawa Y; Takahashi R H; Sato Y; Wakabayashi H; Takashima M; Kido H; Nagashima K; Kenney K; Gibbs C J; Kurata T
Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease.
Clinical and diagnostic laboratory immunology 1999;6(6):983-5.
1999: Katano H; Sata T; Suda T; Nakamura T; Tachikawa N; Nishizumi H; Sakurada S; Hayashi Y; Koike M; Iwamoto A; Kurata T; Mori S
Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma.
Journal of medical virology 1999;59(3):346-55.
1999: Katayama H; Hashimoto Y; Kiyokawa E; Nakaya M; Sakamoto A; Machinami R; Kurata T; Mochizuki N; Matsuda M
Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells.
Japanese journal of cancer research : Gann 1999;90(10):1096-103.
1999: Chen Z; Yoshikawa T; Kadowaki S; Hagiwara Y; Matsuo K; Asanuma H; Aizawa C; Kurata T; Tamura S
Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein.
The Journal of general virology 1999;80 ( Pt 10)():2559-64.
1999: Terajima J; Moriishi E; Kurata T; Watanabe H
Preincubation of recombinant Ipa proteins of Shigella sonnei promotes entry of non-invasive Escherichia coli into HeLa cells.
Microbial pathogenesis 1999;27(4):223-30.
1999: Nakajima N; Sata T; Hanaki K; Kurata T; Yoshikura H
Application of the hybridization AT-tailing method for detection of human immunodeficiency virus RNA in cells and simian immunodeficiency virus RNA in formalin-fixed and paraffin-embedded tissues.
Journal of virological methods 1999;81(1-2):169-77.
1999: Hagiwara Y; Komase K; Chen Z; Matsuo K; Suzuki Y; Aizawa C; Kurata T; Tamura S
Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine.
Vaccine 1999;17(22):2918-26.
1999: Katano H; Sato Y; Kurata T; Mori S; Sata T
High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma.
The American journal of pathology 1999;155(1):47-52.
1999: Takahashi H; Takahashi R H; Hasegawa H; Horiuchi M; Shinagawa M; Yokoyama T; Kimura K; Haritani M; Kurata T; Nagashima K
Characterization of antibodies raised against bovine-PrP-peptides.
Journal of neurovirology 1999;5(3):300-7.
1999: Tokunaga K; Ikuta K; Adachi A; Matsuda M; Kurata T; Kojima A
The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell-dependent enhancement of viral entry.
Virology 1999;257(2):285-9.
1999: Ichiba T; Hashimoto Y; Nakaya M; Kuraishi Y; Tanaka S; Kurata T; Mochizuki N; Matsuda M
Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504.
The Journal of biological chemistry 1999;274(20):14376-81.
1999: Sato Y; Asahi Y; Iwasaki T; Matsukura T; Kurata T; Sata T
Detection of adeno-associated virus type 2 in patients with viral infection.
Japanese journal of infectious diseases 1999;52(2):50-1.
1999: Takahashi R H; Nagashima K; Kurata T; Takahashi H
Analysis of human lymphotropic T-cell virus type II-like particle production by recombinant baculovirus-infected insect cells.
Virology 1999;256(2):371-80.
1999: Chen Z; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S
Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.
Vaccine 1999;17(7-8):653-9.
1999: Iwasaki T; Tamura S; Kumasaka T; Sato Y; Hasegawa H; Asanuma H; Aizawa S; Yanagihara R; Kurata T
Exacerbation of influenzavirus pneumonia by intranasal administration of surfactant in a mouse model.
Archives of virology 1999;144(4):675-85.
1998: Kiyokawa E; Hashimoto Y; Kobayashi S; Sugimura H; Kurata T; Matsuda M
Activation of Rac1 by a Crk SH3-binding protein, DOCK180.
Genes & development 1998;12(21):3331-6.
1998: Ogawa-Goto K; Arao Y; Ito Y; Ogawa T; Abe T; Kurata T; Irie S; Akanuma H
Binding of human cytomegalovirus to sulfated glucuronyl glycosphingolipids and their inhibitory effects on the infection.
The Journal of general virology 1998;79 ( Pt 10)():2533-41.
1998: Tokunaga K; Kojima A; Kurata T; Ikuta K; Akari H; Koyama A H; Kawamura M; Inubushi R; Shimano R; Adachi A
Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent.
The Journal of general virology 1998;79 ( Pt 10)():2447-53.
1998: Chen Z; Sahashi Y; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S
Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza.
Vaccine 1998;16(16):1544-9.
1998: Tokunaga K; Kojima A; Kurata T; Ikuta K; Inubushi R; Shimano R; Kawamura M; Akari H; Koyama A H; Adachi A
Producer cell-dependent requirement of the Nef protein for efficient entry of HIV-1 into cells.
Biochemical and biophysical research communications 1998;250(3):565-8.
1998: Kiyokawa E; Hashimoto Y; Kurata T; Sugimura H; Matsuda M
Evidence that DOCK180 up-regulates signals from the CrkII-p130(Cas) complex.
The Journal of biological chemistry 1998;273(38):24479-84.
1998: Asanuma H; Aizawa C; Kurata T; Tamura S
IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration.
Vaccine 1998;16(13):1257-62.
1998: Hashimoto Y; Katayama H; Kiyokawa E; Ota S; Kurata T; Gotoh N; Otsuka N; Shibata M; Matsuda M
Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor.
The Journal of biological chemistry 1998;273(27):17186-91.
1998: Tokunaga K; Kiyokawa E; Nakaya M; Otsuka N; Kojima A; Kurata T; Matsuda M
Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck.
Journal of virology 1998;72(7):6257-9.
1998: Brandful J A; Ampofo W K; Janssens W; Adu-Sarkodie Y; Apeagyei F; Anyomi F; Aidoo S; Yamamoto N; Ishikawa K; Sata T; Kurata T
Genetic and phylogenetic analysis of HIV type 1 strains from southern Ghana.
AIDS research and human retroviruses 1998;14(9):815-9.
1998: Ota S; Kizaka-Kondoh S; Hashimoto Y; Nishihara H; Nagashima K; Kurata T; Okayama H; Matsuda M
Constitutive association of EGF receptor with the CrkII-23 mutant that inhibits transformation of NRK cells by EGF and TGF-beta.
Cellular signalling 1998;10(4):283-90.
1998: Narita M; Ando Y; Soushi S; Kurata T; Arao Y
The BglII-N fragment of herpes simplex virus type 2 contains a region responsible for resistance to antiviral effects of interferon.
The Journal of general virology 1998;79 ( Pt 3)():565-72.
1998: Tamura S; Iwasaki T; Thompson A H; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
The Journal of general virology 1998;79 ( Pt 2)():291-9.
1998: Komase K; Tamura S; Matsuo K; Watanabe K; Hattori N; Odaka A; Suzuki Y; Kurata T; Aizawa C
Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine.
Vaccine 1998;16(2-3):248-54.
1998: Iwasaki T; Sata T; Kurata T
[Pathology of human cytomegalovirus infection in immunocompromised hosts]
Nippon rinsho. Japanese journal of clinical medicine 1998;56(1):115-20.
1997: Tamura S; Yajima A; Hatori E; Tamura S; Asanuma H; Suzuki Y; Aizawa C; Kurata T
Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection.
Vaccine 1997;15(16):1784-90.
1997: Arao Y; Soushi S; Sato Y; Moriishi E; Ando Y; Yamada M; Padilla J; Uno F; Nii S; Kurata T
Infection of a human retinal pigment epithelial cell line with human herpesvirus 6 variant A.
Journal of medical virology 1997;53(2):105-10.
1997: Ichiba T; Kuraishi Y; Sakai O; Nagata S; Groffen J; Kurata T; Hattori S; Matsuda M
Enhancement of guanine-nucleotide exchange activity of C3G for Rap1 by the expression of Crk, CrkL, and Grb2.
The Journal of biological chemistry 1997;272(35):22215-20.
1997: Iwasaki T; Maeda H; Kameyama Y; Moriyama M; Kanai S; Kurata T
Presence of a novel hamster oral papillomavirus in dysplastic lesions of hamster lingual mucosa induced by application of dimethylbenzanthracene and excisional wounding: molecular cloning and complete nucleotide sequence.
The Journal of general virology 1997;78 ( Pt 5)():1087-93.
1997: Asanuma H; Thompson A H; Iwasaki T; Sato Y; Inaba Y; Aizawa C; Kurata T; Tamura S
Isolation and characterization of mouse nasal-associated lymphoid tissue.
Journal of immunological methods 1997;202(2):123-31.
1997: Tamura S; Hatori E; Tsuruhara T; Aizawa C; Kurata T
Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin.
Vaccine 1997;15(2):225-9.
1997: Ando Y; Iwasaki T; Sata T; Soushi S; Kurata T; Arao Y
Enhanced cytopathic effect of human cytomegalovirus on a retinal pigment epithelium cell line, K-1034, by serum-free medium.
Archives of virology 1997;142(8):1645-58.
1997: Kiyokawa E; Mochizuki N; Kurata T; Matsuda M
Role of Crk oncogene product in physiologic signaling.
Critical reviews in oncogenesis 1997;8(4):329-42.
1997: Sakae H; Kohase M; Kurata T; Yoshikura H
Isolation of a measles virus variant: protection of newborn mice from measles encephalitis by 24 h prior intracerebral inoculation with the variant.
Archives of virology 1997;142(10):1937-52.
1996: Matsuda M; Kurata T
Emerging components of the Crk oncogene product: the first identified adaptor protein.
Cellular signalling 1996;8(5):335-40.
1996: Matsuda M; Ota S; Tanimura R; Nakamura H; Matuoka K; Takenawa T; Nagashima K; Kurata T
Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins.
The Journal of biological chemistry 1996;271(24):14468-72.
1996: Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(10):3892-900.
1996: Hasegawa H; Kiyokawa E; Tanaka S; Nagashima K; Gotoh N; Shibuya M; Kurata T; Matsuda M
DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane.
Molecular and cellular biology 1996;16(4):1770-6.
1995: Asanuma H; Inaba Y; Aizawa C; Kurata T; Tamura S
Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase.
Journal of immunological methods 1995;187(1):41-51.
1995: Tamura S; Ishihara K; Miyata K; Aizawa C; Kurata T
Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin.
Vaccine 1995;13(4):339-41.
1995: Asanuma H; Koide F; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Tamura S
Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration.
Vaccine 1995;13(1):3-5.
1995: Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
Intervirology 1995;38(5):269-73.
1994: Tachibana Y; Yasuda A; Kurata T; Oka S; Shimada K; Kojima A
Major antigenic region on the integrase (IN) protein of human immunodeficiency virus type 1 determined by reactivity of human sera and a monoclonal antibody to IN protein.
Clinical and diagnostic laboratory immunology 1994;1(6):678-83.
1994: Tamura S; Shoji Y; Hasiguchi K; Aizawa C; Kurata T
Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin.
Vaccine 1994;12(13):1238-40.
1994: Matsuda M; Hashimoto Y; Muroya K; Hasegawa H; Kurata T; Tanaka S; Nakamura S; Hattori S
CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells.
Molecular and cellular biology 1994;14(8):5495-500.
1994: Tamura S; Asanuma H; Ito Y; Yoshizawa K; Nagamine T; Aizawa C; Kurata T
Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice.
Vaccine 1994;12(4):310-6.
1994: Maeda A; Sata T; Sato Y; Kurata T
A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases.
Virchows Archiv : an international journal of pathology 1994;424(2):121-8.
1993: Abe K; Kurata T; Teramoto Y; Shiga J; Shikata T
Lack of susceptibility of various primates and woodchucks to hepatitis C virus.
Journal of medical primatology 1993;22(7-8):433-4.
1993: Tanaka S; Hattori S; Kurata T; Nagashima K; Fukui Y; Nakamura S; Matsuda M
Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells.
Molecular and cellular biology 1993;13(7):4409-15.
1993: Tanaka S; Matsuda M; Nagata S; Kurata T; Nagashima K; Shizawa Y; Fukui Y
Structure of 85 kDa subunit of human phosphatidylinositol 3-kinase analyzed by using monoclonal antibodies.
Japanese journal of cancer research : Gann 1993;84(3):279-89.
1993: Matsuda M; Nagata S; Tanaka S; Nagashima K; Kurata T
Structural requirement of CRK SH2 region for binding to phosphotyrosine-containing proteins. Evidence from reactivity to monoclonal antibodies.
The Journal of biological chemistry 1993;268(6):4441-6.
1993: Maeda A; Sata T; Enzan H; Tanaka K; Wakiguchi H; Kurashige T; Yamanishi K; Kurata T
The evidence of human herpesvirus 6 infection in the lymph nodes of Hodgkin's disease.
Virchows Archiv. A, Pathological anatomy and histopathology 1993;423(1):71-5.
1992: Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(3):981-8.
1992: Matsuda M; Tanaka S; Nagata S; Kojima A; Kurata T; Shibuya M
Two species of human CRK cDNA encode proteins with distinct biological activities.
Molecular and cellular biology 1992;12(8):3482-9.
1992: Hirabayashi Y; Tamura S I; Shimada K; Kurata T
Involvement of antigen-presenting cells in the enhancement of the in vitro antibody responses by cholera toxin B subunit.
Immunology 1992;75(3):493-8.
1992: Tamura S I; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
European journal of immunology 1992;22(2):477-81.
1992: Gizurarson S; Tamura S; Aizawa C; Kurata T
Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit.
Vaccine 1992;10(2):101-6.
1992: Arao Y; Yoshida M; Sata T; Nakatsukasa A; Miyoshi K; Yamada M; Uno F; Kurata T; Nii S
Detection of herpes simplex and varicella-zoster virus DNA by field-inversion gel electrophoresis from clinical materials.
Microbiology and immunology 1992;36(11):1217-21.
1992: Nagata S; Okamoto Y; Inoue T; Ueno Y; Kurata T; Chiba J
Identification of epitopes associated with different biological activities on the glycoprotein of vesicular stomatitis virus by use of monoclonal antibodies.
Archives of virology 1992;127(1-4):153-68.
1991: Gizurarson S; Tamura S; Kurata T; Hasiguchi K; Ogawa H
The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane.
Vaccine 1991;9(11):825-32.
1991: Hoshikawa N; Kojima A; Yasuda A; Takayashiki E; Masuko S; Chiba J; Sata T; Kurata T
Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
The Journal of general virology 1991;72 ( Pt 10)():2509-17.
1991: Nagata S; Kurata T; Ueno Y; Chiba J
Vesicular stomatitis virus-mediated cell fusion subsequent to virus adsorption at different pH values.
Japanese journal of medical science & biology 1991;44(4):171-80.
1991: Nagata S; Yamamoto K; Ueno Y; Kurata T; Chiba J
Preferential generation of monoclonal IgG-producing hybridomas by use of vesicular stomatitis virus-mediated cell fusion.
Hybridoma 1991;10(3):369-78.
1991: Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
European journal of immunology 1991;21(6):1337-44.
1991: Nagata S; Yamamoto K; Ueno Y; Kurata T; Chiba J
Production of monoclonal antibodies by the use of pH-dependent vesicular stomatitis virus-mediated cell fusion.
Hybridoma 1991;10(2):317-22.
1991: Hirabayashi Y; Tamura S I; Suzuki Y; Nagamine T; Aizawa C; Shimada K; Kurata T
H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin.
Immunology 1991;72(3):329-35.
1990: Kikuta K; Hirabayashi Y; Nagamine T; Aizawa C; Ueno Y; Oya A; Kurata T; Tamura S
Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccines combined with cholera toxin B subunit.
Vaccine 1990;8(6):595-9.
1990: Tamura S; Funato H; Hirabayashi Y; Kikuta K; Suzuki Y; Nagamine T; Aizawa C; Nakagawa M; Kurata T
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.
Vaccine 1990;8(5):479-85.
1990: Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
Vaccine 1990;8(3):243-8.
1990: Kikuta K; Kurata H; Nagamine T; Aizawa C; Ueno Y; Kurata T; Tamura S
Enhancement of DTH response by cholera toxin B subunit inoculated intranasally together with influenza HA vaccine.
Microbiology and immunology 1990;34(3):337-46.
1990: Kurata T; Iwasaki T; Sata T; Wakabayashi T; Yamaguchi K; Okuno T; Yamanishi K; Takei Y
Viral pathology of human herpesvirus 6 infection.
Advances in experimental medicine and biology 1990;278():39-47.
1989: Tamura S; Funato H; Nagamine T; Aizawa C; Kurata T
Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB.
Vaccine 1989;7(6):503-5.
1989: Tamura S; Kurata H; Funato H; Nagamine T; Aizawa C; Kurata T
Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit.
Vaccine 1989;7(4):314-20.
1989: Tamura S I; Samegai Y; Kurata H; Kikuta K; Nagamine T; Aizawa C; Kurata T
Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine.
Vaccine 1989;7(3):257-62.
1989: Abe K; Kurata T; Shikata T
Non-A, non-B hepatitis: visualization of virus-like particles from chimpanzee and human sera.
Archives of virology 1989;104(3-4):351-5.
1988: Tamura S; Samegai Y; Kurata H; Nagamine T; Aizawa C; Kurata T
Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.
Vaccine 1988;6(5):409-13.
1988: Ohtaki S; Hondo R; Kodama H; Kurata T
Experimental activation of latent cytomegalovirus infection of the captive bred (F1) cynomolgus monkeys by live or killed varicella-zoster virus inoculated under immunosuppression.
Acta pathologica japonica 1988;38(8):967-78.
1988: Abe K; Kurata T; Shikata T; Tennant B C
Enzyme-altered liver cell foci in woodchucks infected with woodchuck hepatitis virus.
Japanese journal of cancer research : Gann 1988;79(4):466-72.
1988: Abe K; Kurata T; Yamada K; Okumura H; Shikata T
Establishment and characterization of a woodchuck hepatocellular carcinoma cell line (WH44KA).
Japanese journal of cancer research : Gann 1988;79(3):342-9.
1988: Abe K; Kurata T; Shikata T
Localization of woodchuck hepatitis virus in the liver.
Hepatology (Baltimore, Md.) 1988;8(1):88-92.
1988: Tamura S; Samegai Y; Kurata H; Kurata T
Effects of cholera toxin on delayed-type hypersensitivity to sheep red blood cells inoculated intranasally into mice.
Microbiology and immunology 1988;32(11):1145-61.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Takeshi Kurata

Research Profile (preview)

Living Beings

Procedures

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Takeshi Kurata (preview)

All Publications